Status:

UNKNOWN

Tracers for Endometrial Cancer Sentinel Node Labeling

Lead Sponsor:

University Medical Centre Maribor

Conditions:

Endometrial Cancer

Sentinel Lymph Node

Eligibility:

FEMALE

18-85 years

Phase:

NA

Brief Summary

Sentinel lymph node (SLN) biopsy is currently used in the management of vulvar and breast cancers as well as in malignant melanoma, and is being intensively studied in patients with cervical and endom...

Eligibility Criteria

Inclusion

  • Histologically proven endometrial cancer (any tumour type).
  • Apparent early-stage endometrial cancer with intermediate or high risk prognostic factors (deep myometrial invasion or G2/G3 disease or non- endometrioid histological type), no evidence of bulky or suspicious pelvic/para-aortic lymph nodes or distant metastases on preoperative conventional imaging studies; minimum requirement for clinical staging includes expert US or pelvic MRI for local staging and abdominal US or abdominal CT scan or PET CT for distant staging.
  • Performance status ECOG: 0-1.
  • Age ≥18, ≤85.
  • History of second primary cancer only if more than 5 years with no evidence of disease.
  • Approved and signed informed consent form to participate in the study.

Exclusion

  • Pregnancy
  • Desire for fertility sparing
  • History of pelvic or abdominal radiotherapy

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2024

Estimated Enrollment :

83 Patients enrolled

Trial Details

Trial ID

NCT04665544

Start Date

January 1 2021

End Date

January 1 2024

Last Update

June 14 2021

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

University Hospital Ostrava

Ostrava, Czechia

2

Charles University-First Faculty of Medicine, University Hospital Bulovka, Department of Gynecology and Obstetrics

Prague, Czechia

3

Gynecologic Oncology Center, Department of Obstetrics and Gynecology; First Faculty of Medicine, Charles University of Prague and General Hospital in Prague

Prague, Czechia

4

KNTB Zlin

Zlín, Czechia

Tracers for Endometrial Cancer Sentinel Node Labeling | DecenTrialz